
0.7333 Delayed Data As of Mar 29 | ![]() Today’s Change | 0.71 Today|||52-Week Range 6.26 | -67.55% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $138.4M |
Nektar Therapeutics 455 Mission Bay Boulevard South San Francisco California 94158 |
Howard W. Robin | President, Chief Executive Officer & Director |
Jillian B. Thomsen | Senior VP, Chief Financial & Accounting Officer |
Kevin Brodbeck | Senior Vice President-Technical Operations |
Jonathan Zalevsky | Chief Research & Development Officer |
Brian L. Kotzin | Chief Medical Officer & Senior Vice President |